Mediobanca Banca di Credito Finanziario SpA (0HBF)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 25.10 |
|---|---|
| 52-week range | 14.52 – 29.22 |
| Return, 1 month / 3 months | −11.7% / −7.3% |
| Return, 1 year / 3 years | +65.3% / +187.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 31 |
| Volatility (1 year) | 30.4% |
| Worst drawdown (1 year) | -21.5% |
| Average daily value traded | 1.03M EUR |
| Dividend yield | 4.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mediobanca Banca di Credito Finanziario is an Italian banking group based in Milan. It provides corporate and investment banking services, including advisory on mergers and acquisitions, capital raising and lending, to companies, financial institutions and public bodies. The group also serves households and small businesses through consumer credit and wealth management activities. Its clients include large corporations, institutional investors and retail customers, mainly in Italy and other European markets.
On this site Mediobanca Banca di Credito Finanziario SpA appears as a stock on the London Exchange (UK), code 0HBF, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mediobanca Banca di Credito Finanziario SpA (0HBF) trades on the London Exchange in UK. It last closed at EUR 25.10 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 550 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 65.3% and over the last three months it fell 7.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.5% | ||
| From 52-week high | -13.7% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -7.3% | ||
| 6-month return | 25.2% | ||
| 12-month return, skipping the last month | 87.3% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.5% | ||
| Liquidity | 53 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.03M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 85 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.9% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.4% |
|---|---|
| 1 month | −11.7% |
| 3 months | −7.3% |
| 6 months | +25.2% |
| 1 year | +65.3% |
| 3 years | +187.7% |
| 5 years | +255.4% |
Signals
| 50-day / 200-day average | 27.74 / 22.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.62 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Apr 2026 | EUR 0.6300 |
| 24 Nov 2025 | EUR 0.5900 |
| 19 May 2025 | EUR 0.5600 |
| 18 Nov 2024 | EUR 0.5600 |
| 20 May 2024 | EUR 0.5100 |
| 20 Nov 2023 | EUR 0.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.